MCK · News · 20260805N
Revenue Performance and Mix
MCKESSON CORP · 2026-08-05 · Importance 34 · Surprise 32 · In source text
McKesson reported fiscal Q1 2027 revenue of $105.38 billion, up 7.7% year over year and ahead of consensus estimates by 0.95%. Growth was driven by the U.S. Pharmaceutical business, oncology services and specialty medicines, although pricing dynamics moderated revenue momentum. Medical-Surgical Solutions revenue increased 4% year over year to $2.8 billion. The results reflected stronger prescription volumes and demand for specialty pharmaceuticals.
Key facts
- Q1 fiscal 2027 revenues: $105.38 billion. source
- Q1 revenue increase year-over-year: 7.7%. source
- Investing.com noted analysts expect robust earnings and revenue growth for McKesson's fiscal first-quarter, but the prior quarter had a significant revenue miss. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | — | Q1 fiscal 2027 revenues: $105.38 billion. |